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Serotonin and cholecystokinin synergistically stimulate rat
vagal primary afferent neurones
Y. Li, X. Y. Wu and C. Owyang
Gastroenterology Research Unit, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
Recent studies indicate that cholecystokinin (CCK) and serotonin (5-hydroxytryptamine,
5-HT) act via vagal afferent fibres to mediate gastrointestinal functions. In the present
study, we characterized the interaction between CCK and 5-HT in the vagal primary afferent
neurones. Single neuronal discharges of vagal primary afferent neurones innervating
the duodenum were recorded from rat nodose ganglia. Two groups of nodose ganglia
neurones were identified: group A neurones responded to intra-arterial injection of low
doses of cholecystokinin octapeptide (CCK-8; 10–60 pmol); group B neurones responded only
to high doses of CCK-8 (120–240 pmol), and were also activated by duodenal distention.
CCK-JMV-180, which acts as an agonist in high-affinity states and as an antagonist in
low-affinity states, dose dependently stimulated group A neurones, but inhibited the effect
of the high doses of CCK-8 on group B neurones. Duodenal perfusion of 5-HT evoked
dose-dependent increases in nodose neuronal discharges. Some neurones that responded
to 5-HT showed no response to either high or low doses of CCK-8. A separate group of
nodose neurones that possessed high-affinity CCK type A (CCK-A) receptors also responded
to luminal infusion of 5-HT. Further, a subthreshold dose of CCK-8 (i.e. 5 pmol) produced
no measurable electrophysiological effects but it augmented the neuronal responses to
5-HT. This potentiation effect of CCK-8 was eliminated by CR 1409. From these results we
concluded that the vagal nodose ganglion contains neurones that may possess only high- or
low-affinity CCK-A receptors or 5-HT3 receptors. Some neurones that express high-affinity
CCK-A receptors also express 5-HT3 receptors. Pre-exposure to luminal 5-HT may augment
the subsequent response to a subthreshold dose of CCK.
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The vagal nerve conveys primary afferent information
from the intestinal mucosa to the brainstem. Activation
of vagal afferent fibres results in inhibition of food intake,
gastric emptying, and pancreatic secretion (Ritter et al.
1992; Li & Owyang, 1993, 1996; Schwartz & Moran, 1998).
Electrophysiological studies indicate that exogenous
cholecystokinin (CCK) stimulates vagal afferent fibres or
the brainstem neurones (Davison & Clark, 1988; Richards
et al. 1996). In a previous study using the nodose ganglia
recording technique, we showed that CCK acted on both
high- and low-affinity CCK-A receptors present on distinct
vagal afferent fibres. The vagal CCK receptor field includes
the regions innervated by gastric, coeliac and hepatic vagal
branches (Li et al. 1999).
It has been demonstrated that intestinal perfusion
of solutions with osmotic pressures ranging from 4 to
1100 mOsm, or perfusion of carbohydrates, increased
vagal afferent firings (Mei & Garnier, 1986). Investigators
have also reported that serotonin (5-hydroxytryptamine,
5-HT) increased the discharge of vagal afferent fibres
from the stomach and proximal intestine of the ferret. We
(Zhu et al. 2001), and others (Andrews & Davison, 1990;
Blackshaw & Grundy, 1993), and have provided electro-
physiological evidence that endogenously released 5-HT
plays a major role in the signal transmission evoked by
luminal factors to stimulate vagal nodose neurones.
Thus, endogenously released CCK and 5-HT are potent
stimuli of vagal primary afferent neurones (Li et al. 1999;
Zhu et al. 2001). Both responses are completely blocked by
acute vagotomy and luminal anaesthetic, which suggests
that both CCK and 5-HT may activate vagal afferent
neurones via a paracrine or endocrine action after release
from the intestinal mucosa. 5-HT and CCK are both
implicated in pancreatic secretion, in the stimulation of
gastrointestinal reflexes, and in the modulation of feeding
behaviour. 5-HT is thought to play a role in visceral
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nociceptive mechanisms (Emeran & Gebhart, 1994; Bueno
et al. 1997). In addition, 5-HT is involved in the regulation
of motility and sensation in the gut (Grider et al. 1998;
De Ponti & Tonini, 2001).
We have shown that, similar to CCK,
non-CCK-mediated luminal stimuli such as osmolality,
disaccharides, and mechanical stimulation, induce 5-HT
release from intestinal enterochromaffin cells, which in
turn activate 5-HT3 receptors on vagal afferent fibres to
mediate luminal factor-stimulated pancreatic enzyme
secretion (Li et al. 2000). In this manner, 5-HT acts as
a paracrine substance to stimulate pancreatic secretion
via a vagal cholinergic pathway (Li et al. 2001). Further,
we have shown that infusion of a subthreshold dose of
CCK potentiates vagal–vagal reflex-mediated pancreatic
secretion stimulated by luminal 5-HT-dependent factors
(Li & Owyang, 1996), which suggests that CCK and 5-HT
may act synergistically to stimulate the vagal afferent
pathway. Both CCK and 5-HT play an important role
in the mediation of pancreatic enzyme secretion (Li
& Owyang, 1993; Li et al. 2000, 2001). Together they
account for most if not all postprandial pancreatic enzyme
secretion. However, little is known about CCK and 5-HT
interaction in vagal primary afferent neurones. We
hypothesize that CCK and 5-HT may act separately on the
nodose ganglion but they may also act synergistically to
stimulate a specific population of vagal primary afferent
neurones. In the current investigation, we performed
electrophysiological studies in rats to determine the
pattern of distribution of high- and low-affinity CCK-A
and 5-HT3 receptors on vagal nodose neurones, and we
examined the nature of the interaction between CCK and
5-HT in vagal primary afferent neurones.
Methods
Materials
5-HT, maltose and protease were purchased from
Sigma-Aldrich (St Louis, MO). Cholecystokinin
octapeptide (CCK-8, CR 1409 and L-365 260 were
purchased from Research Biochemical International
(Natick, MA), granisetron was purchased from
GlaxoSmithKline Pharmaceuticals (Philadelphia,
PA) and CCK-JMV-180 was purchased from Research
Plus (Manasquan, NJ).
Animal preparation
Experiments were performed on adult male
Sprague-Dawley rats weighing 270–350 g that had
been given free access to food and water. The animals were
anaesthetized with a mixture of xylazine and ketamine
(13 and 87 mg (kg body weight)−1, respectively).
Supplemental doses of the anaesthetic agents were
administered as needed to maintain a deep level of
anaesthesia and muscle relaxation (supplemental doses
of one-quarter of the initial dose were given every
hour throughout the experiment or when a 20%
increase in the rat’s heart rate (50–60 beats min−1)
above the level following the initial dose of anesthetic was
observed). To prevent any undesirable movements, neuro-
muscular block was induced with pancuronium bromide
(initial dose, 0.1 mg kg−1, i.v.; supplementary dose,
0.05 mg kg−1 h−1). The animals were ventilated with a
respirator – a tracheal tube permitted artificial ventilation
with room air (75–85 strokes min−1, 3.5–4.0 cm3 tidal
volumes). A midline abdominal incision exposed the
abdominal vagus, the stomach and the duodenum.
Stimulation of the subdiaphragmatic vagus nerve was
accomplished by placing a pair of Teflon-coated, pure
gold wire electrodes (outside diameter, 76 µm) around
the anterior and posterior trunks, about 2–3 cm above the
gastroesophageal junction and above the accessory and
coeliac branches of the vagus nerve. These stimulating
electrodes were loosely sutured to the oesophagus to limit
displacement. At the end of each experiment, an overdose
of anaesthetic was administered to kill the animals. All
experimental procedures were approved by the University
Committee on Use and Care of Animals at the University
of Michigan.
Recording of single nodose neuronal activity
Rats were placed in a small animal stereotaxic frame
(Kopf). Body temperature was maintained with a special
heating pad. The right nodose ganglion was exposed by a
short dorsal approach. Using an operating microscope,
the ganglion sheath was removed and separated from the
adjacent cervical sympathetic trunk and carotid artery.
Protease (type XIV, 0.3 mg ml−1) was applied to the
ganglion for 15 min. The recording microelectrodes were
pulled from glass capillaries (A-M Systems, Everett, WA)
using a micropipette puller and microelectrode beveller
to obtain tips between 0.08 and 0.1 µm in diameter with a
resistance of 50–70 M. The bevelled glass micropipette
filled with 1.0 m KCl was lowered into the nodose
ganglion. Once a nodose ganglion neurone activated
by the electrical vagal stimulation was identified, the
response of that neurone to intra-arterial injection of
CCK-8 and intraduodenal perfusion of test solutions was
measured. A reference electrode was placed on a skin
incision near the recording electrode. Recordings were
only from gastrointestinal C-fibres, which were identified
according to the following parameters measured in
response to electrical stimulation of the abdominal
vagus nerve: latency (60–80 ms); conduction distance
between the stimulating electrode and the nodose
ganglion (0.06 m); and conduction velocity (< 1.0 m s−1).
Neuronal discharges recorded extracellularly were
amplified by an A-M System high input-impedance
C© The Physiological Society 2004
J Physiol 559.2 5-HT and CCK mediate nodose neuronal activity 653
pre-amplifier, monitored with an oscilloscope and audio
monitor, displayed and stored on an IBM-compatible
computer using Axon tape software. The basal discharge
was monitored for 2 min to confirm the stability of the
basal firing frequency. Consistent monitoring of each
neurone was ensured by careful study of the firing pattern
produced by each neurone and also by studying the
amplitude and waveform of each spike.
Experimental design
Vagal nodose neuronal responses to CCK-8,
CCK-JMV-180 and duodenal distention
CCK-8 and CCK-JMV-180 studies. The superior
pancreaticoduodenal artery, which mainly supplies
the duodenum (Hebel & Stromberg, 1976), was
cannulated. The common hepatic artery was exposed
and temporarily ligated. The gastroduodenal artery was
punctured at its junction with the common hepatic artery.
The catheter was inserted and threaded into the superior
pancreaticoduodenal artery about 0.5 cm past the gastro-
epiploic artery (Cox, 1998). The catheter was fixed in
place with a suture, and the puncture hole was sealed with
cyanoacrylate glue. Once a stable single nodose neuronal
recording was established, 1-min basal spontaneous
firings were recorded. The neuronal responses to bolus
injections of various doses of CCK (10, 30, 60, 120, and
240 pmol) into the superior pancreaticoduodenal artery
were examined.
CCK-JMV-180 has been shown to interact with both
classes of pancreatic CCK receptors, acting as an agonist
in high-affinity states and as an antagonist in low-affinity
states (Sato et al. 1989; Stark et al. 1989). We have
previously shown that intravenous (i.v.) infusion of
CCK-JMV-180 produces a dose-dependent increase in
pancreatic protein secretion via a capsaicin-sensitive
vagal afferent pathway (Li et al. 1997). In contrast,
CCK-JMV-180 has also been shown to block the
suppression of food intake by CCK; this is mediated by
vagal low-affinity CCK-A receptors in rats (Weatherford
et al. 1993). To identify the vagal CCK-A receptor
affinity state that mediates CCK-evoked vagal afferent
activities, we performed CCK-JMV-180 dose–response
studies. CCK-JMV-180 (dissolved in dimethyl sulfoxide,
Tween 80 and sterile 0.15 m NaCl; 8:1:1, v:v:v) was injected
intra-arterially at doses of 1.0 and 4.0 µg. A maximum
of five different doses of CCK-8 and CCK-JMV-180
or vehicle were delivered randomly in each neurone
study. Recording was continued for 3 min, leaving 5 min
between each dose. The neurones that did not respond to
CCK-8 were discarded. A different neurone was identified
after electrical stimulation of the subdiaphragmatic vagus
nerve, and the experimental procedure was repeated.
Responses to CCK were examined before and after i.v.
administration of the CCK-A receptor antagonist CR 1409
and the CCK-B receptor antagonist L-365 260.
CCK receptor antagonist studies. Previous studies have
shown that both CCK-A and CCK-B binding sites are
transported towards the periphery of the rat vagus
nerve (Julian & Lawrence, 1992). To determine whether the
vagal afferent neuronal response evoked by intra-arterial
injection of CCK-8 and CCK-JMV-180 involved either
the CCK-A receptor or the CCK-B receptor, we
examined the effects of the CCK-A receptor antagonist
CR 1409 (10 mg kg−1 i.v. bolus injection, dissolved in
0.005 M NaOH) and the CCK-B receptor antagonist
L-365 260 (3.5 µmol kg−1 h1, dissolved DMSO, Tween
80 and NaCl as above). It has been shown in the
anaesthetized rat that the peptide antagonist CR 1409
prevented cerulein-stimulated pancreatic secretion in
a dose-dependent manner. At a dose of 10 mg kg−1,
CR 1409 abolished the pancreatic response to a
near-maximum dose of cerulein (Niederau et al. 1989).
Previously, we have shown that administration of CR
1409 but not the CCK-B antagonist L-365 260 completely
abolished the nodose neuronal responses to endogenous
CCK stimulation (Li et al. 1999). In addition, the effects
of the CCK receptor antagonist L-364 718 (0.5 mg kg−1
i.v. bolus) or vehicle (4% DMSO/polysorbate 80) were
examined in the current studies (Li & Owyang, 1996; Li
et al. 1997).
In the anaesthetized rat, L-365 260 dose-dependently
inhibited pentagastrin-induced stimulation of gastric acid
secretion, with an ID50 of 2.5 µmol kg−1 h−1 (Attoub
et al. 1998). Vagal nodose neuronal responses to CCK
were monitored as previously described. The CCK-A and
CCK-B receptor antagonists or vehicles were administered
10 min before CCK-8 administration.
Duodenal distention studies. Nodose ganglion neurones
that respond to distention probably innervate the muscle
layer, whereas those that respond to intestinal chemo-
stimulation innervate the mucosa. To characterize the
nodose neurones that were activated by CCK in the
present study, we examined the responses of CCK-sensitive
neurones to duodenal distention. Distention of the closed
intestinal loop was achieved by closing the distal cannula
and infusing 3 ml isotonic saline. Constant pressure
distention was regulated by a distention control device.
Intraduodenal pressure was monitored by connecting the
distal catheter to a pressure transducer via a three-way
stopcock. Animals with a cannula inserted into the
duodenum but not distended (0 mmHg) served as control.
Under our experimental conditions, infusion of 3 ml
saline into a 20-cm isolated segment of intestine increased
luminal pressure to 6–8 mmHg producing a non-noxious
stimulation (Ness, 1988; Renehan et al. 1995).
Atropine and hexamethonium studies. High doses of
CCK-8 may act on the vagal CCK-A receptors located
on the muscle layer. Therefore, the vagal nodose
neurones activated by CCK-8 may be stimulated by
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intestinal muscle contraction. To rule the possibility out
that the nodose neuronal response to CCK was a result
of an increase in muscle tone, secondary to the action of
CCK on muscle itself, we performed an atropine study.
Atropine (100 µg kg−1 h−1) was infused 10 min before
injection of CCK. Similar studies were performed with
hexamethonium (15 mg kg−1 bolus plus 7.5 mg kg−1 h−1
continuous infusion) to examine the role of pre-synaptic
cholinergic neurones in the mediation of CCK-stimulated
nodose neuronal firing.
Vagal nodose neuronal responses to CCK-8 plus
CCK-JMV 180
In a separate study, we examined the effects of
CCK-JMV-180, on the vagal neuronal firings induced by
CCK-8. CCK-8 (various doses) and CCK-JMV-180 (4 µg)
were infused simultaneously; and nodose recording was
repeated as described above.
Vagal nodose neuronal responses to duodenal
perfusion of 5-HT and intra-arterial injection of CCK-8
A 20-cm segment of small intestine, including the entire
duodenum and the proximal jejunum, was isolated
between two cannulas positioned at 4 cm (PE 60; i.d.,
0.76 mm; o.d., 1.22 mm) and 24 cm (PE 190; i.d., 1.19 mm;
o.d., 1.7 mm) from the pylorus. The cannulae were fixed in
the intestine with sutures. After 1-min recordings at basal
level, 5-HT (10−5 and 10−3 m, 1.5 ml) was administered
intraduodenally at separate intervals. The distal cannula
was kept open to permit drainage and to avoid an increase
in intraluminal pressure. The two test solutions were
delivered randomly over 1 min and then washed out using
a syringe filled with isotonic NaCl. The recording of the
nodose neurone continued for 3 min with a 10-min resting
period between experiments. If a positive response to
luminal stimuli was observed, that same neurone was
used for CCK-8 dose–response studies as described above.
The 5-HT3 antagonist granisetron (0.5 mg kg−1, i.v.) and
the CCK-A antagonist CR 1409 were administered to a
separate group of rats.
Interaction between CCK and luminal 5-HT
Because a group of neurones possessing high-affinity
CCK-A receptors also responded to luminal infusion
of 5-HT, we examined the nature of the interaction
between CCK and 5-HT in vagal primary afferent
neurones. Electrophysiological recordings of nodose
neurones in response to intraduodenal perfusion of 5-HT
and intra-arterial injection of CCK-8 were performed.
After 1-min basal spontaneous firings were recorded, the
neuronal responses to bolus injections of CCK-8 at doses of
5, 10 and 30 pmol were examined. When CCK-stimulated
nodose neuronal responses were observed, those particular
neurones were tested for their responsiveness to intra-
duodenal perfusion of 10−5 m 5-HT as described above.
After rinsing the intestinal lumen with buffer solution,
the discharge frequency always decreased. Neurones
that exhibited an increased basal discharge frequency
(> 4 impulses (20 s)−1) were not tested further. After a
5-min resting period, an intra-arterial injection of CCK-8
(5, 10 or 30 pmol) was administered as the duodenum was
re-perfused with 5-HT. The effects of the CCK-A receptor
antagonist CR-1409 were examined.
Data analysis
The single neuronal responses were examined using the
Datapac software system 2000 (Run Technologies, Laguna
Hills, CA) (Mei & Garnier, 1986). The pre-stimulus
discharge frequency was assessed for 1 min to quantify
the resting discharge. The discharge frequency after
administration of CCK-8 or CCK-JMV-180 and after
duodenal luminal perfusion of 5-HT was measured for
3 min. Time histograms were constructed for the 1-min
period before the intestinal infusion of 5-HT and for the
2-min period after stimulation. The mean and standard
deviation of nodose neuronal firing during the 30-s
control period was compared with the maximal activity
after the administration of the stimulus. A positive
response was defined as an increase of 2 s.d.s from
the mean in the maximal activity after the infusion of
CCK-8, CCK-JMV-180 or luminal 5-HT, compared to the
mean firing rate in the control period. The results were
compared with those obtained after the pharmacological
interventions. Results were expressed as means ± s.e.m.
Significance tests were carried out using the appropriate
Student paired or unpaired t test with the Newman-Keuls
tests (InStat Biostatistics 2.01. Graphpad Software, Inc.)
when multiple comparisons were made. P < 0.01 was
considered statistically significant.
Results
Effects of CCK-8 and CCK-JMV-180 on nodose
neuronal activity
Data were collected from 141 recordings of single nodose
ganglia neurones in 39 rats. All 141 neurones activated by
electrical stimulation of the subdiaphragmatic vagus nerve
were tested with intra-superior pancreaticoduodenal
artery injection of CCK (5, 10, 30, 60, 120 and 240 pmol),
and CCK-JMV-180 (1.0 and 4.0 µg). At most, five
different doses of CCK-8 and two doses of CCK-JMV-180
were tested in each neurone. A total of 24 neurones
(17%) responded to intra-arterial injections of CCK and
CCK-JMV-180. All neurones displayed either silent or
very low spontaneous activity (0–1.5 impulses (20 s)−1)
before infusion of CCK-8 or CCK-JMV-180. Injection of
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CCK at dose of 5 pmol produced no measurable electro-
physiological effect. In all cases, the threshold dose of
CCK was greater than 5 pmol. The short latency of the
CCK response (i.e. 1.0 ± 0.3 s) was probably the result of
intra-arterial administration; CCK reached the intestinal
mucosa soon after injection. Of the 24 neurones, two
groups of vagal afferent neurones could be identified.
Group A neurones (17 neurones) responded to low doses
of CCK-8 (10, 30 and 60 pmol). The magnitude of the
response was dependent on dose; the firing rate increased
from 0 ± 0.5 to 6 ± 1, 15 ± 3 and 34 ± 6 impulses (20 s)−1,
respectively (Fig. 1A and B). The response reached a
plateau at 60 pmol CCK-8. The mean duration of the
responses was 45.7 ± 2.7 s. Injection of CCK-8 at a dose of
120 pmol evoked a lesser response (4.5 impulses (20 s)−1)
and at 240 pmol, this group of neurones failed to respond.
An example of the original action potential record
is presented in Fig. 1. In contrast, group B neurones
(seven neurones) responded to high doses of CCK (120
and 240 pmol); the firing rate increased from basal the
basal level (0 ± 1) to 21 ± 3 and 33 ± 5 impulses (20 s)−1,
respectively. Low doses of CCK-8 had no effect on
group B neurones. Only one neurone responded to both
Figure 1. Response of a nodose ganglia neurone to intra-superior pancreaticoduodenal artery infusions
of CCK-8 and CCK-JMV-180 and to intestinal volume distention
Intra-arterial infusion of CCK-8 at doses of 30 pmol (A) and 60 pmol (B) produced a dose-dependent increase in
nodose neuronal discharge frequency. C, administration of CCK-8 at 240 pmol evoked only a slight increase in
nodose neuronal firing. D, administration of CCK-JMV-180 produced a marked increase in vagal afferent discharge
in the same neurone as in A, which indicates the presence high-affinity CCK-A receptors on a subgroup of vagal
primary afferent neurones. However, this same neurone failed to respond to intestinal distention (E).
low and high doses of CCK. This particular neurone was
also activated by duodenal distention.
Administration of CCK-JMV-180 (1.0 and 4.0 µg)
stimulated 13 of 24 neurones; nodose neuronal firings
increased to 5.5 ± 0.2 and 19 ± 2 impulses (20 s)−1,
respectively. All 13 neurones were activated by low
doses of CCK. None of the neurones activated by
high doses of CCK-8 responded to CCK-JMV-180. The
mean discharge frequency of nodose ganglia neurones in
response to various doses of CCK-8 is presented in Figs 2
and 3.
Of the 24 neurones activated by intra-arterial injection
of CCK or CCK-JMV-180, five neurones were tested to
determine whether stimulated response could be blocked
by administration of the CCK-A receptor antagonist CR
1409. Indeed, CR 1409 abolished the responses to CCK-8
and CCK-JMV-180 in all five neurones. Four neurones
were tested after administration of the CCK-B receptor
antagonist L-365 260. L-365 260 had no effect on nodose
neuronal firings stimulated by CCK-8 and CCK-JMV-180.
The mean discharge frequency of the nodose ganglia
neurones in response to various stimuli is presented
in Figs 3 and 4. Administration of the CCK-A receptor
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antagonist L-364 718 completely abolished nodose
neuronal responses to CCK-8 and CCK-JMV-180 in
another three neurones tested.
Sensitivity of CCK-sensitive neurones
to duodenal distention
Twenty-four neurones were tested for their responsiveness
to duodenal distention. Volume distention elicited
a powerful increase in discharge frequency
(39 ± 3 impulses (20 s)−1), which was maintained
throughout the period of distention. The vagal afferent
neurones that were activated by a low dose of CCK-8 failed
to respond to volume distention (Fig. 1E). In contrast,
five of seven neurones that were activated by high doses
of CCK-8 responded to duodenal distention, but failed
to respond to CCK-JMV-180, which suggests that those
neurones expressing low-affinity CCK-A receptors also
respond to duodenal distention.
Administration of atropine or hexamethonium
The effect of atropine on CCK-8-stimulated nodose
neuronal firings was examined in six neurones. Of the
six neurones, five neurones were activated both by high
doses of CCK-8 and by duodenal volume distention,
Figure 2. Discharges of group A nodose ganglia neurones in response to intra-arterial injections of
CCK-8 and CCK-JMV-180 and to intestinal volume distention
Of 141 neurones activated by electrical vagal stimulation, 24 neurones responded to intra-arterial injection of
CCK-8 and CCK-JMV-180. Of these 24 neurones, two groups of neurones were identified. The discharge of group
A neurones, which responded to low doses of CCK-8, were used for the analysis shown in this figure. Administration
of CCK-8 at doses of 10, 30 and 60 pmol dose-dependently increased neuronal discharges. This group of
neurones did not respond to high doses of CCK-8 (i.e. 120 and 240 pmol), and they failed to respond to intestinal
volume distention. Twenty of 24 group A neurones were activated by intra-arterial injection of CCK-JMV-180.
Administration of the CCK-A receptor antagonist CR 1409, but not the CCK-B receptor antagonist L-365,260,
abolished nodose neuronal responses evoked by CCK-8 and CCK-JMV-180. Administration of CCK-JMV-180 in
combination with CCK-8 (30 pmol) produced a further increase of neuronal firings compared with administration
of CCK-8 alone. The filled bar represents the mean value of the neuronal discharges in response to CCK-8 (30 pmol)
plus CCK-JMV-180. Values are means ± S.E.M. ∗P < 0.01 compared with vehicle; ∗∗P < 0.01 compared with CCK-8
at 30 pmol.
but CCK-JMV-180 evoked no response. The effect of
hexamethonium was examined in nine neurones. Of
these, four neurones were activated by both high doses
of CCK-8 and duodenal distention, but failed to respond
to CCK-JMV-180. We showed that administration of
atropine or hexamethonium had no effect on vagal afferent
neuronal firing in response to high doses of CCK-8
(Fig. 3), nor did this treatment affect the neuronal firing
induced by duodenal distention.
Effects of CCK-JMV-180 on nodose neuronal activity
stimulated by CCK-8
Data were collected from 21 recordings of single nodose
ganglia neurones in 30 rats. All 21 units activated by
electrical stimulation of the subdiaphragmatic vagus nerve
were tested with intrasuperior pancreaticoduodenal artery
injection of CCK-8 (30, 60, 120 and 240 pmol). Of the
21 neurones, 12 were activated by intra-arterial injection of
various doses of CCK-8. Of these 12 neurones, seven were
stimulated by low doses of CCK-8 (group A), and five were
sensitive to high doses of CCK-8 (group B). To identify
the vagal CCK-A receptor affinity state that mediates
CCK-evoked vagal afferent neuronal firings, all 12
neurones were tested after administration of
CCK-JMV-180 (4 µg). All of the group A neurones
were stimulated by CCK-JMV-180; neuronal discharges
C© The Physiological Society 2004
J Physiol 559.2 5-HT and CCK mediate nodose neuronal activity 657
increased to 19 ± 1.5 impulses (20 s)−1. In addition,
CCK-8 at doses of 5 and 30 pmol were injected in
combination with CCK-JMV-180. Administration of
CCK-8 in combination with CCK-JMV-180 significantly
augmented the nodose neuronal firings in four of seven
neurones tested. The average discharge frequency is
presented in Fig. 3. In group B, all five neurones were
tested. Administration of CCK-JMV-180 (4 µg) produced
an 80% inhibition of the nodose neuronal firings
stimulated by high doses of CCK-8 (120 and 240 pmol).
The average discharge frequency is presented in Fig. 3.
Effects of intraluminal infusions of 5-HT on nodose
neuronal activity
Data were collected from 32 single neuronal recordings
of nodose ganglia in 18 rats. All 32 units activated
by electrical stimulation of the subdiaphragmatic vagus
nerve were tested with intraduodenal perfusion of 5-HT
(10−5 and 10−3 m). Nine of the 32 units responded to intra-
duodenal perfusion of 5-HT. Intestinal perfusion of 10−5
and 10−3 m 5-HT increased nodose neuronal discharges
to 25 ± 6 and 47 ± 6 impulses (20 s)−1, respectively. The
test solutions were delivered randomly over 1 min. After
the intestinal lumen was rinsed with buffer solution, the
discharge frequency decreased gradually.
We showed that i.v. administration of the 5-HT3
receptor antagonist granisetron abolished the response
to luminal perfusion of 5-HT in four of four neurones
tested. On the other hand, we found that administration
Figure 3. Discharges of group B nodose ganglia neurones in response to intra-arterial injections of CCK-8
and CCK-JMV-180 and to intestinal volume distention
A, discharges of the group B neurones that responded to high doses of CCK-8 (i.e. 120 and 240 pmol). Neither
administration of CCK at low doses nor administration of CCK-JMV-180 stimulated this group of neurones.
In contrast to group A neurones, intestinal distention markedly increased the neuronal discharge frequency.
Administration of atropine or hexamethonium however, had no effect on neuronal discharge stimulated by CCK-8.
B, in a separate study of the 12 neurones, five were activated by high doses of CCK-8. This group of neurones did
not respond to CCK-JMV-180. Administration of CCK-JMV-180 produced an 80% inhibition of neuronal responses
stimulated by the 240 pmol dose of CCK-8. The filled bar represents the mean values of the neuronal discharges in
response to CCK-8 (240 pmol) plus CCK-JMV-180. ∗P < 0.01 compared with vehicle; ∗∗P < 0.01 compared with
CCK-8 at 240 pmol.
of the 5-HT4 receptor antagonist GR125487 had no effect
on the response to luminal 5-HT (data not shown).
Of the nine neurones activated by intraduodenal perfusion
of 5-HT, five responded to intra-arterial injection of
CCK-8; four of nime neurones failed to respond to CCK-8
at any dose. Administration of granisetron had no effect
on the nodose neuronal responses induced by CCK-8. In
contrast, administration of the CCK-A receptor antagonist
CR 1409 inhibited the responses evoked by intra-arterial
CCK-8 injection, but had no effect on luminal
5-HT-induced nodose neuronal firings in another three
of three neurones recorded. The average discharge
frequency of nodose ganglia neurones in response to
luminal 5-HT, and the effects of CR 1409 and granisetron
are presented in Fig. 4.
Interaction between CCK-8 and luminal
perfusion of 5-HT
Data were collected from 40 single neuronal recordings
of nodose ganglia in 17 rats. All 40 neurones activated
by electrical stimulation of the subdiaphragmatic vagus
nerve were tested with intra-arterial injection of CCK-8.
A subthreshold dose of CCK (i.e. 5 pmol) produced
no measurable electrophysiological effect. Eleven of 40
neurones were activated by intra-arterial injection of CCK
at a dose of 30 pmol; nodose firings increased from basal
level (0 ± 0.5) to 16 ± 1.8 impulses (20 s)−1. Of the 11
neurones that responded to CCK-8, six were activated
after luminal perfusion of 10−5 m 5-HT; firings increased
from 1 ± 0.5 to 22.5 ± 3.5 impulses (20 s)−1. We showed
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that intra-arterial injection of a subthreshold dose of CCK
(5 pmol) augmented the neuronal response to luminal
5-HT (Fig. 5). In addition, we showed that a 30 pmol
dose of CCK further augmented neuronal firings when
the luminal 5-HT perfusion was simultaneous.
To further clarify the synergistic interaction between
these two agents, an additional study was performed
in 10 rats. Twelve of 35 neurones activated by
electrical stimulation of the subdiphragmatic vagus
nerve were stimulated with an intra-arterial injection of
CCK-8 at a dose of 10 pmol. Nodose neuronal firings
increased from 0 ± 0.5 to 5.8 ± 0.5 impulses (20 s)−1.
Of these 12 neurones, seven were activated after
luminal perfusion of 5-HT; firing increased from 1 ± 0.5
to 19.5 ± 2.5 impulses (20 s)−1. During intraduodenal
perfusion of 5-HT, intra-arterial injection of CCK
(10 pmol) evoked an increase in discharge frequency to
36 ± 3 compared with 20.5 ± 3.5 impulses (20 s)−1 after
vehicle (saline) injection. The total increase in neuronal
discharge was greater than the sum of neuronal discharges
stimulated by CCK-8 and luminal 5-HT alone, suggesting
a potentiation effect of these two agents on vagal nodose
neuronal activities. Administration of the CCK-A receptor
antagonist CR 1409 eliminated the augmented responses
induced by CCK-8. The mean discharge frequency of the
nodose neurones is shown in Fig. 6.
Discussion
In the present study, using the nodose ganglia recording
technique in anaesthetized rats, we showed that the vagal
Figure 4. Responses of nodose ganglia neurones activated by both intraluminal perfusion of 5-HT and
intra-arterial injection of CCK-8
Of 32 neurones activated by electrical vagal stimulation, luminal perfusion of 5-HT (10−5 and 10−3 M)
dose-dependently stimulated nodose neuronal firing in nine neurones A, administration of the 5-HT3 receptor
antagonist granisetron but not the CCK-A receptor antagonist CR 1409, eliminated nodose neuronal responses
evoked by luminal 5-HT stimulation. B, of the nine neurones that responded to luminal perfusion of 5-HT, five were
activated by intra-arterial injection of low doses (i.e. 30 and 60 pmol) but not a high dose (240 pmol) of CCK-8.
Administration of the CCK-A receptor antagonist CR 1409, but not the 5-HT3 receptor antagonist granisetron
eliminated the neuronal responses evoked by CCK-8. Values are means ± S.E.M.
nodose ganglion contains neurones that may possess high-
or low-affinity CCK-A receptors or 5-HT3 receptors.
Some neurones that express high-affinity CCK-A receptors
also contain 5-HT3 receptors, so prior exposure to
subthreshold doses of CCK may augment the subsequent
response to luminal 5-HT.
Vagal afferent fibres represent a major target for CCK,
mediating many digestive functions (Li & Owyang, 1993,
1996; Smith et al. 1981). CCK has been shown to stimulate
gastric muscle mechanoreceptors in the rat (Davison
& Clarke, 1988; Schwartz & Moran, 1998) although
inhibition of gastric motor activity by CCK-8 has also
been reported. However, electrophysiological studies
suggest that mucosal afferents in the gastroduodenal
region appear to be stimulated by CCK in the ferret and
the rat (Li & Owyang, 1993; Richards et al. 1996). CCK
dose–response studies using pancreatic acini typically
reveal a biphasic dose–response relationship. Although
clearly defined subtypes of the type A receptor have not
been identified, CCK has been shown to interact with two
different affinity states in pancreatic acinar cells (Sato et al.
1989; Stark et al. 1989). One site has high affinity and low
capacity and is associated with stimulation of pancreatic
enzyme release at CCK concentrations up to 100 pm. The
other site has low affinity and high capacity and is thought
to mediate the inhibition of CCK-stimulated pancreatic
enzyme release. It is not known whether these two sites
represent distinct proteins or different affinity states of the
same receptor protein. The COOH-terminal heptapeptide
CCK analogue CCK-JMV-180 provides a functional
discrimination between these two states. CCK-JMV-180
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has been shown to interact with both classes of pancreatic
CCK receptors, acting as an agonist at the high-affinity
state and an antagonist at the low-affinity state (Sato et al.
1989; Stark et al. 1989). Another study (Li et al. 1997)
demonstrated that activation of gastric mechanosensitive
vagal afferent fibres and suppression of food intake by
CCK in the rat were mediated by vagal low-affinity
CCK-A receptors. We have shown that, in contrast to its
effect on satiety, i.v. infusion of CCK-JMV-180 stimulates
pancreatic secretion to a similar degree to that evoked by
a physiological dose of CCK-8. CCK-JMV-180 did not
inhibit but rather augmented the pancreatic responses to
both exogenous and endogenous CCK, which suggests
that under physiological conditions, CCK acts through
high-affinity CCK-A receptors to mediate pancreatic
protein secretion (Weatherford et al. 1993). These
responses were abolished by vagotomy, which suggests
mediation by high-affinity CCK-A receptors. Further,
electrophysiological recording of the nodose ganglion
neurones, showed that administration of CCK-JMV-180
inhibited the neuronal response to endogenously released
CCK during diversion of bile-pancreatic juice in some but
not all neurones (Li et al. 1999). Therefore, both low-
and high-affinity CCK receptors must coexist in the vagal
nodose ganglion. Activation of these CCK receptors in
Figure 5. Effect of the interaction
between CCK-8 and 5-HT on nodose
neuronal firing
Intra-arterial infusion CCK-8 at a dose
of 30 pmol (B), but not 5 pmol (A)
increased nodose neuronal firing.
Intraduodenal infusion of 10−5 M 5-HT
stimulated the same neurone (C).
D, administration of the subthreshold
dose of CCK-8 (i.e. 5 pmol) enhanced
the nodose neuronal response to 5-HT
(10−5 M). E, administration of saline
had no effect on the nodose neuronal
response to 5-HT (10−5 M).
different affinity states may mediate different digestive and
metabolic functions.
In the current study, we examined the single vagal
nodose neuronal responses to intra-arterial injection of
CCK-8 at various doses and showed that CCK-8 clearly
can act on both high- and low-affinity CCK-A receptors
found on a distinct population of nodose neurones. The
mechanisms underlying the phenomenon of low-dose
CCK stimulation and high-dose CCK inhibition of a
certain group or population of CCK-sensitive afferents
are unclear; however, our previous investigations have
demonstrated that protein kinase C (PKC) might be
involved in this negative feedback regulation. When
dispersed pancreatic acini were incubated with the
high-affinity CCK-A receptor agonist CCK-JMV-180 and
the PKC activator, an inhibition of enzyme secretion was
observed (Tsunoda & Owyang, 1995; Lankisch et al. 2002).
The activation of PKC may cause phosphorylation of
serine or threonine on the CCK-A receptor, resulting in
desensitization of the receptor (Ozcelbi & Miller, 1995).
Therefore, it appears that PKC activated by high-dose
CCK inhibits the activity of the high-affinity CCK-A
receptor. A similar mechanism may operate within the
vagal afferent fibres bearing low- and high-affinity CCK
receptors.
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Most of the neurones (5 of 7) activated by high doses
of CCK-8 also responded to duodenal distention, which
suggests that these afferent fibres are polymodal and their
terminals are located in the intestinal muscle layer. These
neurones possessed low-affinity CCK-A receptors as they
did not respond to CCK-JMV-180.
We showed that administration of atropine or
hexamethonium had no effect on vagal afferent neuronal
firing in response to high doses of CCK-8, nor did
this treatment affect the neuronal firing induced by
duodenal distention. These observations suggest that the
vagal nodose neuronal response evoked by intra-arterial
injection of high doses of CCK-8 was not the result of
an increase in muscle tone, secondary to the action of
CCK on the intestinal muscle itself or on the enteric
cholinergic pathway, which are known to stimulate
intestinal contraction. CCK-8 also does not act via a
pre-synaptic cholinergic pathway to stimulate nodose
neuronal firing.
Enterochromaffin cells have been shown to secrete 5-HT
spontaneously and in response to a wide variety of stimuli.
Large numbers of 5-HT-containing cells are found in
the proximal duodenum. These cells have a morphology
that is consistent with a paracrine ‘sensory’ role. It is
interesting that a CCK-A receptor antagonist has been
reported to reduce the vagal afferent-mediated inhibitory
effects on gastric emptying induced by intra-intestinal
infusion of maltose (Raybould & Hölzer, 1992), leading
to the suggestion that carbohydrates may stimulate CCK
Figure 6. Discharge of nodose ganglia neurones in response to intra-arterial injection of CCK-8 and
intraluminal perfusion of 5-HT, and the effect of the interaction between CCK-8 and 5-HT
Of the 40 neurones activated by electrical stimulation of the vagus nerve, a subthreshold dose of CCK (i.e.
5 pmol) produced no measurable electrophysiological effect. Eleven of 40 neurones were activated by intra-arterial
injection of CCK at a dose of 30 pmol. Of the 11 neurones that responded to CCK-8, six were activated after
luminal perfusion of 5-HT. Intra-arterial injection of a subthreshold dose of CCK (5 pmol) enhanced the neuronal
responses to luminal 5-HT. Furthermore, injection of CCK (30 pmol) against a background luminal perfusion of
5-HT produced a further increase of neuronal firing. Administration of the CCK-A receptor antagonist CR 1409
eliminated the enhanced responses induced by CCK-8. ∗P < 0.01 compared with vehicle; ∗∗P < 0.01 compared
with 5-HT- control.
release, which in turn activates vagal afferent fibres.
In a recent electrophysiological study, we showed that
intraduodenal perfusions of maltose, glucose and hyper-
tonic saline stimulated nodose ganglion in rats (Zhu
et al. 2001). These vagal primary afferent neurones were
also sensitive to exogenous luminally applied 5-HT at
concentrations that mimicked physiological levels. Intra-
venous administration of a 5-HT3 antagonist blocked
these responses, which suggests that nodose neuronal
responses to luminal osmolarity and to the digestion
products of carbohydrates are mediated by the release
of endogenous 5-HT from the mucosal enterochromaffin
cells. This released 5-HT acts on the 5-HT3 receptors on
vagal afferent fibres.
Given the facts that endogenously released 5-HT and
CCK both act on vagal afferent fibres innervating the
intestinal mucosa to stimulate vagal afferent neurones,
and, as we observed in a previous study, infusion of
a subthreshold dose of CCK potentiated vagal–vagal
reflex-mediated pancreatic secretion stimulated by
luminal 5-HT-dependent factors (Li & Owyang, 1996),
it is possible that 5-HT and CCK may activate the same
population of nodose ganglia neurones. Inconsistency
currently surrounds the interaction of 5-HT and CCK
in the vagal afferent nerve. Previous research involving
electrophysiological recording from filaments of afferent
fibres of the cervical vagus in the ferret reported that
a number of single units that responded to systemic
administration of 5-HT were activated by CCK-8
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(Blackshaw & Grundy, 1993). However, recording single
unit firings extracted from mesenteric nerve bundles
of the rat showed that individual units responded
either to CCK or to 5-HT, but not to both (Hillsley
& Grundy, 1998). In our current study, using single
vagal afferent neuronal recording, we demonstrated that
there were nodose neurones that responded to luminal
perfusion of 5-HT, but not to different doses of CCK-8.
However, five of nine nodose ganglion neurones that
were activated by CCK-8 also responded to intra-
luminal perfusion of 5-HT. Similarly, six of 11 nodose
neurones possessing high-affinity CCK-A receptors also
responded to luminal perfusion of 5-HT. Interestingly, we
showed that although a subthreshold dose of CCK-8
produced no measurable electrophysiological effects, it
augmented the neuronal response to luminal 5-HT
perfusion. The potentiation effect was eliminated by a
CCK-A receptor antagonist.
The interaction between CCK and 5-HT at the level
of the nodose ganglion may modulate afferent post-
prandial signals arising from the gastrointestinal tract and
thus influence the central nervous system regulation of
gastrointestinal functions. This positive interaction may
explain the augmented response of pancreatic secretion to
CCK after stimulation by 5-HT-dependent luminal stimuli
(Li & Owyang, 1996) and it may provide an explanation of
how a small increase in the plasma CCK level is sufficient
to produce a robust postprandial pancreatic secretion.
Previous research has shown that vagal afferent fibres
respond to gastric load, duodenal load and close
coeliac arterial administration of CCK (Schwartz et al.
1991, 1995). CCK administration potentiates subsequent
responses to gastrointestinal perfusion of nutrients
(Schwartz et al. 1991, 1995). It is well known that the satiety
induced by CCK results from its interaction with other
signals triggered by stimuli within the gastrointestinal
tract. Previous studies have shown that duodenal glucose
infusion, which activates vagal primary afferent neurones
by the release of 5-HT (Zhu et al. 2001; Li et al.
2001) enhances suppression of sham feeding by CCK
(Cox, 1994). The positive interaction between CCK
and 5-HT on the vagal primary afferent neurones, as
demonstrated in the current study, may contribute to
maximizing the satiety action of CCK. In addition,
the positive interaction between CCK and 5-HT at the
level of vagal nodose ganglion may have other physio-
logical and clinical implications. Alosetron has been
reported to significantly reduce pain scores after colorectal
distention (De Ponti & Tonini, 2001), and clinical
trials have demonstrated that the drug is moderately
effective in controlling symptoms in female patients with
irritable bowel syndrome (Talley, 2003). Most patients
with irritable bowel syndrome also show an exaggerated
response to CCK in colonic motility and visceral pain
(Roberts-Thomson et al. 1992). The present study showed
that 5-HT and CCK-8 may act synergistically to stimulate
vagal primary afferent neurones; an observation that
may provide a functional basis to help explain why
most patients with irritable bowel syndrome exhibit CCK
hypersensitivity.
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